Why Did SPCX, IBM, BSX Drop To 52-Week Lows Today?
SpaceX, IBM and Boston Scientific fell to 52-week lows on Wednesday as Wall Street concerns and profit-taking sent the stocks lower.
Archived explainer. For the current picture see today's BSX page.
BOSTON SCIENTIFIC CO (BSX) is drawing unusual attention today. Our newswire has captured 1 story on BSX across 1 source in the last 36 hours, with AI sentiment reading bearish (avg 28/100).
Boston Scientific Co (BSX) is moving lower today after hitting a 52-week low. The stock opened with a small gap higher but quickly reversed course amid broader market concerns and profit-taking. The decline follows a string of analyst price target reductions and a deteriorating sentiment trend.
Boston Scientific fell to a 52-week low on Wednesday as Wall Street concerns and profit-taking sent the stock lower. The stock opened at $43.35, a 0.7% gap up from the previous close, but failed to hold that level. By the end of the session, the stock had settled near $44.57, with a high of $45.45 and a low of $43.04. The stock traded on 4.0 million shares, which is just 0.2 times the 3-month daily average. The recent price action has seen the stock fall 2.4% over the last 8 sessions, from $45.66 to $44.57.
Analysts have maintained positive ratings on the stock but have lowered their price targets. Mizuho, RBC Capital, Needham, and Evercore ISI Group all maintain Outperform or Buy ratings but have reduced their price targets to between $57 and $85. Boston Scientific reported a trailing twelve-month revenue increase of 17.4% and a net margin of 17.3%, but its beta of 0.58 indicates it has been less volatile than the broader market.
The stock’s 52-week range is $42.25 to $109.50, and it is currently trading near the lower end of that range. Unusual options activity has been observed, with $360K in call premium and $269K in put premium traded, the largest single print being $360K. On July 16, the stock printed one fresh 52-week low. Recent insider transactions show three directors buying shares totaling $554K in the last 90 days. Meanwhile, recent congressional trades include both buys and sells, with Rep. Ro Khanna disclosing a recent purchase of $1,001-$15,000.
Boston Scientific does not have an upcoming earnings date listed. Investors should monitor the breadth of analyst coverage and any further price target adjustments.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.
SpaceX, IBM and Boston Scientific fell to 52-week lows on Wednesday as Wall Street concerns and profit-taking sent the stocks lower.
More on BSX: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier BSX move explainers: 2026-07-16